Publications by authors named "Elizabeth J Schafer"
Background And Objective: Our aim was to examine worldwide patterns and trends for prostate cancer (PC) incidence and mortality using high-quality, up-to-date, population-based data.
Methods: We analyzed age-standardized PC incidence and mortality rates by country and region from the 2022 GLOBOCAN estimates and temporal trends in incidence (50 countries/territories) and mortality (59 countries/territories) rates using data from the Cancer Incidence in Five Continents series and the World Health Organization mortality database.
Key Findings And Limitations: Estimated PC rates across regions in 2022 varied 13-fold for incidence and 9.
Previous studies reported higher lung cancer incidence in women than men among persons aged 35-54 years in the United States, a reversal of historically higher rates in men. We examined whether this pattern varies by state. Based on lung cancer incidence (2015-2019) data among adults aged 35-54 years from Cancer in North America database and historical cigarette smoking prevalence data (2004-2005) among adults 20-39 years from the Behavioral Risk Factor Surveillance System, incidence rates in women were equal to or higher than rates in their male counterparts in 40 of 51 states, with statistically significant differences in 20 states (two-sided, p < .
View Article and Find Full Text PDFThe coronavirus disease 2019 (COVID-19) pandemic led to health care disruptions and declines in cancer diagnoses in the United States. However, the impact of the pandemic on cancer incidence rates by stage at diagnosis and race and ethnicity is unknown. This cross-sectional study calculated delay- and age-adjusted incidence rates, stratified by stage at diagnosis and race and ethnicity, and rate ratios (RRs) comparing changes in year-over-year incidence rates (eg, 2020 vs 2019) from 2016 to 2020 for 22 cancer types based on data obtained from the Surveillance, Epidemiology, and End Results 22-registry database.
View Article and Find Full Text PDFArticle Synopsis
- The COVID-19 pandemic significantly disrupted access to cancer care, leading to a decrease in various treatment modalities for newly diagnosed cancer patients in 2020.
- A cohort study examined data from over 3.5 million adults diagnosed with solid tumors between 2018 and 2020 to measure these changes.
- Findings revealed approximately 98,000 fewer surgical procedures, 38,800 fewer chemotherapy treatments, and other reductions in cancer therapies during the first year of the pandemic compared to expected treatment based on previous years.
Background: Previous studies have reported on incidence and mortality patterns for individual genitourinary cancers in the USA. However, these studies addressed individual cancer types rather than genitourinary cancers overall.
Objective: To comprehensively examine disparities and trends in the incidence and mortality for the four major genitourinary cancers (bladder, kidney, prostate, and testis) in the USA.